Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers

Journal of Medical Virology

Volumn 75, Issue 2, 2005, Pages 235-239

  Kohmoto, Madoka ^a   Enomoto, Masaru ^a   Tamori, Akihiro ^a   Habu, Daiki ^a   Takeda, Tadashi ^a   Kawada, Norifumi ^a   Sakaguchi, Hiroki ^a   Seki, Shuichi ^a   Shiomi, Susumu ^a   Nishiguchi, Shuhei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

HBsAg; HBV; HBV mutants; Hepatitis B virus; Lamivudine therapy; YMDD variants

Indexed keywords

LAMIVUDINE;

ADULT; ANTIBODY RESPONSE; ANTIGEN DETECTION; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; MONITORING; QUANTITATIVE ANALYSIS; VIRUS CARRIER; VIRUS DETECTION; VIRUS MUTANT;

ADULT; ANTIVIRAL AGENTS; CARRIER STATE; CHEMILUMINESCENT MEASUREMENTS; DNA, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOASSAY; LAMIVUDINE; MALE; MIDDLE AGED; TIME FACTORS; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 19944427203     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20262     Document Type: Article

References (16)

1. Coleman PF, Chen YC, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
2. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T, Iinuma K, Mushahwar IK. 2004. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115:217-222.
3. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. 1999. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341:1256-1263.
4. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ. 2001. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33:277-286.
5. Gerken G, Gomes J, Lampertico P, Colombo M, Rothaar T, Trippler M, Colucci G. 1998. Clinical evaluation and applications of the Amplicor HBV monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 74:155-165.
6. Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M. 2001. Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine. Hepatol Res 21:76-84.
7. Jen CM, Young KC, Cheng PN, Kao AW, Chang TT. 2001. Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine. J Virol Methods 96:203-210.
8. Kamisango K, Kamogawa C, Sumi M, Goto S, Hirao A, Gonzales F, Yasuda K, Iino S. 1999. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol 37:310-314.
9. Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N. 2003. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. J Clin Microbiol 41:1901-1906.
10. Kohmoto M, Enomoto M, Yano Y, Otani S, Minamitani S, Tamori A, Habu D, Takeda T, Shiomi S, Seki S, Arakawa T, Nishiguchi S. 2003. Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: Comparison with three other assays. Hepatol Res 26:125-133.
11. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. 1998. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339:61-68.
12. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH. 2000. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828-834.
13. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
14. Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
15. Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, Rossau R. 2000. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 38:702-707.
16. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. 1996. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.